The awareness on, and prevalence of, Actinobacilluspleuropneumoniae (Ap) induced pleuropneumonia is increasing worldwide due to the reduction of antimicrobials use. Farms do not usually know which and how many serotypes are endemic to their farm or to replacement stock. On a continuous basis Ceva publishes successful Coglapix® challenge trials against new Ap serotypes and at the same time significant superiority towards major competitors. The same is encouraged at farm level as field trials for the dual purpose in supporting sales and supporting with local field data particularly on lung lesions scoring, antimicrobials use and ROI. A second focus is to increase awareness on not only the death losses due to per-acute and acute, but also the sub-acute manifestations.
Why choose Coglapix®?
Offers a broad protection against all known important serotypes
No side effects such as fever and vomiting are observed
Long lasting Ap protection to the end of any finishing
The Science behind
Comparison of Protectivity and Safety of Two Vaccines against Actinobacillus pleuropneumoniae in a Field Study
Peter Hölzen, Tobias Warnck, Steffen Hoy, Kathleen Schlegel, Isabel Hennig-Pauka and Horst Gaumann
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.
The most efficacious vaccine to protect against reproductive failures & Erysipelas caused by PPV & Ery with exclusive, proven efficacy and maximum safety in its application.
Respiporc Flu 3 and Respiporc Flu Pan H1N1, the registered range of Influenza vaccines, which delivers the broadest protection against Swine Influenza A Virus (swIAV).
You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
Warning message
These pages are not intended for users based in France.
Further, product information presented on these pages may be used by authorized professionals in the veterinary field only and/or may not be available in certain countries and are always subject to local regulatory requirements.
These pages are general information pages. No guarantee is given as to the completeness of the information contained or its compliance with national regulatory requirements. Users should consult the local site of their countries to obtain information that complies with applicable national regulations.